Public Sector Pension Investment Board Grows Stock Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

Public Sector Pension Investment Board boosted its position in USANA Health Sciences, Inc. (NYSE:USNA) by 5.4% in the 2nd quarter, Holdings Channel reports. The fund owned 24,270 shares of the company’s stock after purchasing an additional 1,242 shares during the period. Public Sector Pension Investment Board’s holdings in USANA Health Sciences were worth $1,098,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CWM LLC grew its stake in USANA Health Sciences by 21.8% in the 1st quarter. CWM LLC now owns 1,543 shares of the company’s stock worth $75,000 after acquiring an additional 276 shares during the period. BOKF NA grew its stake in shares of USANA Health Sciences by 274.5% during the 1st quarter. BOKF NA now owns 2,771 shares of the company’s stock valued at $133,000 after buying an additional 2,031 shares during the period. Trexquant Investment LP purchased a new stake in shares of USANA Health Sciences during the 4th quarter valued at $266,000. Price T Rowe Associates Inc. MD grew its stake in shares of USANA Health Sciences by 9.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 5,849 shares of the company’s stock valued at $284,000 after buying an additional 494 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in shares of USANA Health Sciences during the 2nd quarter valued at $340,000. 54.25% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Gilbert A. Fuller sold 674 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $39.69, for a total transaction of $26,751.06. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other USANA Health Sciences news, insider Paul A. Jones sold 6,266 shares of the business’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $38.38, for a total value of $240,489.08. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Gilbert A. Fuller sold 674 shares of the business’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $39.69, for a total transaction of $26,751.06. The disclosure for this sale can be found here. In the last three months, insiders sold 7,940 shares of company stock valued at $311,670. Company insiders own 0.33% of the company’s stock.

USANA Health Sciences Trading Down 1.7 %

Shares of USANA Health Sciences stock opened at $37.26 on Wednesday. The company has a fifty day moving average price of $39.85 and a 200 day moving average price of $43.94. USANA Health Sciences, Inc. has a twelve month low of $36.05 and a twelve month high of $59.85. The stock has a market cap of $709.80 million, a price-to-earnings ratio of 11.61, a price-to-earnings-growth ratio of 1.27 and a beta of 0.90.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. The business had revenue of $212.87 million for the quarter, compared to analysts’ expectations of $218.64 million. During the same period last year, the company posted $0.89 earnings per share. Analysts forecast that USANA Health Sciences, Inc. will post 2.5 earnings per share for the current year.

Analysts Set New Price Targets

USNA has been the subject of several research reports. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. DA Davidson lowered their price objective on shares of USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a research note on Thursday, July 25th.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.